Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The down trend says
Do not go long
Wait for the break out to the up side
Have you seen the down trend since MID MARCH ?
Analyst: Aurora Cannabis (ACB) Stock Is Worthless
December 17, 2019
Down more than 52% over the past 52 weeks, could Canadian marijuana giant Aurora Cannabis (ACB) go to... zero?
One analyst thinks so. Firm founder Gordon Johnson of GLJ Research announced he was initiating coverage of Aurora Cannabis stock with a "sell" rating.
Arguing that "ACB's equity holds no value," he predicted Aurora Cannabis stock will become utterly worthless by the end of 2021, and so proceeded to assign a two-year price target of $0.
ACB down -52.62 YTD.
But long longs still say buy buy buy ACB
When they should be saying BYE BYE BYE to ACB
So new companies do not have to make money.
How about 10 year old ?
Or 20 year old ?
Maybe that is why there is talk of BK ?
Why don't these competitive advantages show up in the price of ACB ?
TCNNF the sector's leader is down 17 % today
I guess you are talking about a very short term trend.
I am talking about the trend that goes back to mid March.
But if are happy. That is OK with me.
Still no break out of ACB to the up side.
Still no WEED break out to the up side.
The Prudent Speculator has a target of 47.22
Dividend Yield = 2.53%
Earnings Per Share (EPS)= 3.01
Market Cap = $ 149.40B
Are you giving up ?
It may get back to 10 again.
Your loser held up good today. Only down about -3%
Are you going to be a buyer under 2 ?
SOXL FECL TQQQ SPL TNA 2 MONTHS
http://www.stockcharts.com/def/servlet/Favorites.CServlet?obj=1401935,26&cmd=show&disp=e
And revenue down 33% last quarter
ACB Return on Equity = -8.65
ACB Revenue Per Share $ 0.3089
ACB Shares Outstanding = 1.09B
ACB 1 Year Return = -56.71%
TOPS
1 All have HLP above zero( black )
2 At lease 3 out of 5 peak on the same day
BOTTOMS
1 All have HLP below zero ( red )
2 At least 3 out of 5 bottom on the same day.
It does not take a chart to know ACB is down 75% from the peak !
But even regulated pot dispensaries are not safe.
What if people keep on dying?
Health department: Vaping data points directly to regulated pot dispensaries
90 people in Massachusetts have been sickened by vapes and three have died.
By Jessica Bartlett
– Reporter, Boston Business Journal
The Massachusetts Department of Public Health on Saturday amplified its allegations that vapes sickening patients came from the regulated cannabis market.
In an email to the Business Journal, a spokeswoman from the agency said that of the six patients who told public health officials that they purchased vapes from the regulated market, only one had also purchased products from an unregulated source. The remaining five people that had only purchased THC products "reported that they did not" purchase any additional vapes from illicit sources, according to the spokeswoman, Ann Scales.
The update directly points to the regulated market as causing several illnesses, though officials have not publicly disclosed the names of any dispensaries involved.
To date, 90 people in Massachusetts have been sickened by vapes and three have died.
The update is the latest in a series of statements from public health officials about whether or not products from the regulated cannabis industry were causing illnesses. On Thursday, the department published for the first time partial data taken from interviews of 49 patients, which showed that 32 said they had purchased THC vapes. Of those, six said they received vapes from regulated Massachusetts marijuana dispensaries.
But it was not immediately clear from disclosed data if the patients purchased vapes from any illicit sources as well. The Department of Public Health first said it was possible patients could have purchased both illicit and legal products, and then told the Boston Globe that "at least one" patient had done so. Scales, the spokeswoman, went further on Saturday and told the Business Journal that only one patient, who had purchased both THC and nicotine vape products, had purchased both illicit and legal products.
The trickle of confusing and incomplete information comes a month after the state agency charged with regulating the still-new marijuana market, the Cannabis Control Commission, began making requests for data on which products sickened patients had been using.
"This should never have needed to become a public conversation," said Shaleen Title, one of five members of the commission. "A regulating agency that needs public health data to regulate should receive that data upon request, especially during a public health crisis. Government agencies that handle patient data are already subject to confidentiality laws and have confidentiality protocols."
Public health officials and cannabis regulators finally reached an accord on Friday afternoon to share information.
But even that process will involve restrictions, with only one party from each agency allowed to view information, along with limits to what each agency can receive.
Cannabis regulators said they would use the data to discern which dispensaries or products might be implicated.
The data, despite being scrubbed of confidential patient information, will be kept from the public.
While regulators parse out which vapes and dispensaries might be a concern, vapes remain off the market. A ban on nicotine vapes, instituted by Gov. Charlie Baker in September, remains in place. The ban is set to expire Dec. 11, and public health officials will develop regulations at that time.
A quarantine on all cannabis vapes is still in effect.
Dividend Yield = 3.22%